Evidence map›Paper›PMID 40964579›Full record

ArticleCureus2025

Late-Onset, Autosomal Dominant, Axonal, Sensorimotor Neuropathy Due to the New Variant c.1A_G in Myelin Protein Zero (MPZ): A Case Report.

Josef Finsterer

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Josef FinstererNeurology, Neurology and Neurophysiology Center, Vienna, AUT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To the best of our knowledge, autosomal dominant Charcot-Marie-Tooth disease type 1B (CMT1B) due to the c.1A>G variant in myelin protein zero (MPZ) has not yet been reported. The patient was a 56-year-old man with slowly progressive atrophy of the distal muscles of the lower limbs that started in his forties. He later developed transient numbness in both feet. One year before presentation, he noticed paresthesia in the distal lower limbs and easy fatigability when walking uphill. His family history revealed hereditary neuropathy in his mother and her two sisters. Genetic testing of his mother and an aunt revealed the new variant c.1A>G in MPZ (p.Met1Val). Clinical neurological examination revealed myopia, hypoacusis, absent tendon reflexes on the upper and lower limbs, mild weakening of the left thumb and right foot extensors, hypoesthesia and hypoalgesia on both soles and dorsum of the feet, and mild pallhypesthesia on the lower limbs. Nerve conduction studies (NCS) revealed severe sensorimotor axonal neuropathy. The index patient also carried the mutation identified in his mother and aunt. The MPZ variant c.1A>G manifests phenotypically with late-onset CMT1B. Neurologists should be aware that hereditary neuropathy can have a late onset and a slowly progressive course over a number of years, with the ability to walk unimpaired into old age.

Indexed as

autosomal dominantaxonal neuropathympz genenerve conduction studiessensorimotor

Identifiers

PMID40964579
PMCPMC12440264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.